NNNN Stock Overview

Profile

Full Name:

Anbio Biotechnology

Sector:

Healthcare

Industry:

Medical Instruments & Supplies

Country:

Germany

IPO:

February 19, 2025

Indexes:

Not included

Website:

http://www.anbio.com

Description:

Anbio Biotechnology focuses on developing innovative biotechnological solutions for healthcare and agriculture, aiming to improve quality of life through advanced research and sustainable practices.

Key Details

Price

$5.77

Market Cap

$253.25 M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$6.71 M(-71.49% YoY)

Annual EPS

$0.02(-77.44% YoY)

PE Ratio

-

Annual ROE

16.47%

Annual Debt To Equity

0.00

Beta

-2.71

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

N/A

Recent annual earnings:

N/A
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

No data about analysts updates

Screeners with NNNN included

No data

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$5.77
NNNN price is $5.77

Price All-time High

$5.77
NNNN price is currently at an all-time high

Price Analysts Target

-
NNNN price consensus analysts' forecast is unknown

Price Most Recent Change

+1.76%
NNNN price was up +1.76% on Feb 21, 2025

Price YTD Change

-
NNNN price ytd change is unknown

Price 3-Year Change

-
NNNN price 3-year change is unknown

Market cap

Market Cap

$253.25 M
NNNN market capitalization is $253.25 million

Market Cap 3-Year Change

-
NNNN market capitalization 3-year change is unknown

Market Cap All-time High

$253.25 M
NNNN market capitalization is currently at an all-time high

Market Cap Sector Rank

57.89%
NNNN market capitalization is higher than 57.89% of companies in Healthcare sector

Technical

Beta

-2.71
NNNN beta is -2.71

200-day SMA

$5.74
NNNN price is currently +0.58% above its 200-day simple moving average

14-day RSI

51.82
NNNN 14-day relative strength index is 51.82

30-day Relative Volume

0.16
NNNN 30-day relative volume is 0.16

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$6.71 M
NNNN annual revenue is $6.71 million

Annual Revenue Analysts Estimate

-
NNNN annual revenue consensus analysts' forecast is unknown

Annual Revenue 1-Year Change

-71.49%
NNNN annual revenue is down -71.49% year-on-year

Annual Revenue Sector Rank

-
NNNN annual revenue is unknown

Profit

Annual Gross Profit

$3.36 M
NNNN annual gross profit is $3.36 million

Annual Gross Margin

50.07%
NNNN annual gross profit margin is 50.07%

Annual Operating Profit

$1.96 M
NNNN annual operating income is $1.96 million

Annual Operating Margin

29.22%
NNNN annual operating profit margin is 29.22%

Annual Net Income

$2.25 M
NNNN annual net profit is $2.25 million

Annual Net Margin

33.58%
NNNN annual net profit margin is 33.58%

EPS

Annual EPS

$0.02
NNNN annual earnings per share is $0.02

Annual EPS Analysts Estimate

-
NNNN annual earnings per share consensus analysts' forecast is unknown

Annual EPS 1-Year Change

-77.44%
NNNN annual earnings per share is down -77.44% year-on-year

Annual EPS Sector Rank

-
NNNN annual earnings per share is unknown

ROA & ROE

Annual ROA

15.14%
NNNN annual return on assets is 15.14%

Annual ROE

16.47%
NNNN annual return on equity is 16.47%

EBIT & EBITDA

Annual EBIT

$2.25 M
NNNN annual earnings before interest & taxes is $2.25 million

Annual EBITDA

$2.27 M
NNNN annual EBITDA is $2.27 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
NNNN price to earnings ratio value is unknown

PE Ratio Sector Rank

-
NNNN price to earnings ratio is unknown

PB Ratio

PB Ratio

13.75
NNNN price to book ratio is 13.75

PB Ratio Sector Rank

94.02%
NNNN price to book ratio is higher than 94.02% of companies in Healthcare sector

PS Ratio

PS Ratio

-
NNNN price to sales ratio value is unknown

PS Ratio Sector Rank

-
NNNN price to sales ratio is unknown

Enterprise value

Enterprise Value

$242.94 M
NNNN enterprise value is $242.94 million

Enterprise Value Sector Rank

59.17%
NNNN enterprise value is higher than 59.17% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-
NNNN EV/EBITDA value is unknown

EV/EBITDA Sector Rank

-
NNNN EV/EBITDA is unknown

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

15.86
NNNN annual current ratio is 15.86

Annual Quick Ratio

15.86
NNNN annual quick ratio is 15.86

Leverage

Annual Debt To Equity

0.00
NNNN annual debt to equity ratio is 0.00

Annual Interest Coverage Ratio

-
NNNN annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
NNNN piotroski f-score value is unknown

Altman Z-Score

156.33
NNNN altman z-score is 156.33

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$15.81 M
NNNN annual total assets is $15.81 million

Annual Non Current Assets

$62.10 K
NNNN annual long term assets is $62.10 thousand

Annual Current Assets

$15.75 M
NNNN annual total current assets is $15.75 million

Annual Cash & Cash Equivalents

$9.69 M
NNNN annual cash & cash equivalents is $9.69 million

Equity

Annual Book Value

$14.82 M
NNNN annual book value is $14.82 million

Annual Working Capital

$14.76 M
NNNN annual working capital is $14.76 million

Liabilities

Annual Total Liabilities

$993.10 K
NNNN annual total liabilities is $993.10 thousand

Annual Total Long Term Liabilities

$0.00
NNNN annual total long term liabilities is $0.00

Annual Current Liabilities

$993.10 K
NNNN annual total current liabilities is $993.10 thousand

Annual Accounts Payable

$827.20 K
NNNN annual accounts payable is $827.20 thousand

Debt

Annual Total Debt

$0.00
NNNN annual total debt is $0.00

Annual Total Debt 1-Year Change

0%
NNNN {parameterFullLabel} has remained unchanged year-on-year

Annual Long Term Debt

-
NNNN annual long term debt value is unknown

Annual Short Term Debt

-
NNNN annual short term debt value is unknown

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$4.75 M
NNNN annual total expenses is $4.75 million

Annual Operating Expenses

$1.40 M
NNNN annual total operating expenses is $1.40 million

Annual Cost Of Goods Sold

$3.35 M
NNNN annual cost of goods sold is $3.35 million

Annual SGA

$1.27 M
NNNN annual SGA is $1.27 million

Annual D&A

$12.10 K
NNNN annual depreciation & amortization is $12.10 thousand

Annual Interest Expense

$0.00
NNNN annual interest expense is $0.00

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

$898.40 K
NNNN annual cash flow from operations is $898.40 thousand

Annual CFO 1-Year Change

-79.81%
NNNN annual cash flow from operations is down -79.81% year-on-year

Annual CFI

$1.73 M
NNNN annual cash flow from investing activities is $1.73 million

Annual CFI 1-Year Change

+213.24%
NNNN annual cash flow from investing activities is up +213.24% year-on-year

Annual CFF

-$42.80 K
NNNN annual cash flow from financing activities is -$42.80 thousand

Annual CFF 1-Year Change

-100%
NNNN annual cash flow from financing activities is down -100% year-on-year

Free CashFlow

Annual FCF

$898.40 K
NNNN annual free cash flow is $898.40 thousand

Annual FCF 1-Year Change

-79.81%
NNNN annual free cash flow is down -79.81% year-on-year

CAPEX

Annual CAPEX

-
NNNN annual capital expenditures value is unknown

Annual CAPEX 1-Year Change

-
NNNN annual capital expenditures 1-year change is unknown

Institutional Ownership

Similar stocks

AVIR logo
Atea Pharmaceuticals (AVIR)
TNGX logo
Tango Therapeutics (TNGX)
DRUG logo
Bright Minds Biosciences (DRUG)
VNDA logo
Vanda Pharmaceuticals (VNDA)
ELDN logo
Eledon Pharmaceuticals (ELDN)
BNTC logo
Benitec Biopharma (BNTC)
YMAB logo
Y-mAbs Therapeutics (YMAB)
TVGN logo
Tevogen Bio Holdings (TVGN)
NGNE logo
Neurogene (NGNE)

FAQ

  • What is the ticker symbol for Anbio Biotechnology Class A?
  • Does Anbio Biotechnology Class A pay dividends?
  • What sector is Anbio Biotechnology Class A in?
  • What industry is Anbio Biotechnology Class A in?
  • What country is Anbio Biotechnology Class A based in?
  • When did Anbio Biotechnology Class A go public?
  • Is Anbio Biotechnology Class A in the S&P 500?
  • Is Anbio Biotechnology Class A in the NASDAQ 100?
  • Is Anbio Biotechnology Class A in the Dow Jones?
  • When does Anbio Biotechnology Class A report earnings?

What is the ticker symbol for Anbio Biotechnology Class A?

The ticker symbol for Anbio Biotechnology Class A is NASDAQ:NNNN

Does Anbio Biotechnology Class A pay dividends?

No, Anbio Biotechnology Class A does not pay dividends

What sector is Anbio Biotechnology Class A in?

Anbio Biotechnology Class A is in the Healthcare sector

What industry is Anbio Biotechnology Class A in?

Anbio Biotechnology Class A is in the Medical Instruments & Supplies industry

What country is Anbio Biotechnology Class A based in?

Anbio Biotechnology Class A is headquartered in Germany

When did Anbio Biotechnology Class A go public?

Anbio Biotechnology Class A's initial public offering (IPO) was on February 19, 2025

Is Anbio Biotechnology Class A in the S&P 500?

No, Anbio Biotechnology Class A is not included in the S&P 500 index

Is Anbio Biotechnology Class A in the NASDAQ 100?

No, Anbio Biotechnology Class A is not included in the NASDAQ 100 index

Is Anbio Biotechnology Class A in the Dow Jones?

No, Anbio Biotechnology Class A is not included in the Dow Jones index

When does Anbio Biotechnology Class A report earnings?

The date for Anbio Biotechnology Class A's next earnings report has not been announced yet